Pelthos Therapeutics Q1 EPS $(3.09) Beats $(3.81) Estimate, Sales $10.906M Beat $10.445M Estimate

Benzinga Newsdesk www.benzinga.com Negative 96.4%

Neg 96.4% Neu 0% Pos 0%

Pelthos Therapeutics (AMEX:PTHS) reported quarterly losses of $(3.09) per share which beat the analyst consensus estimate of $(3.81) by 18.9 percent. The company reported quarterly sales of $10.906 million which beat the analyst consensus estimate of $10.445 million by 4.41 percent.